Real-time enrollment status for this gastroparesis clinical trial
Current Status
Completed
Checked: April 18, 2026 at 12:23 AM UTC
| NCT Number | NCT05621811 |
| Recruiting Status | Completed |
| Condition | Gastroparesis |
| Phase | Clinical Trial |
| Target Enrollment | 320 participants |
| Active Locations | 21 sites in the US |
| Sponsor | Dr. Falk Pharma GmbH |
| Last Updated on CT.gov | April 15, 2026 (3 days ago) |
As of April 18, 2026: Clinical trial NCT05621811 is currently completed participants. This clinical trial study for gastroparesis is not currently accepting new participants at 21 locations across the United States. The study is sponsored by Dr. Falk Pharma GmbH. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05621811 is currently completed. The study may resume recruiting in the future.
This trial is recruiting at 21 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05621811 was last updated 3 days ago (April 15, 2026). HelloStudys verifies this status automatically.